Objective-Coronary occlusive disease is the main cause of late mortality after cardiac transplantation. It has both similarities and differences compared with conventional atherosclerotic coronary disease. The pathophysiology of late graft failure from coronary occlusive disease is unclear at present. We reviewed the experience of this disorder in our cardiac transplant programme.
We documented the incidence and time to occurrence of any form of coronary occlusive disease as apparent from coronary angiography at our hospital. We reviewed the available data from post mortem examination of patients who died during the study, and examined some of the processes which led to graft failure.
Patients and methods A total of 383 patients received their first cardiac transplant at Papworth Hospital between January 1979 and June 1990. Most (88%) of the recipients were male (n = 338). The mean age of these patients was 44 (range 6-63) years at the time of operation. Ischaemic heart disease (53%) and dilated cardiomyopathy (43%) were the main indications for transplantation. supply 12% (3/26) of the occluded coronary arteries in our study. The severity of coronary stenosis produced by coronary occlusive disease was usually modest. For example, of the angiograms showing coronary occlusive disease in the left anterior descending coronary artery, 55% (61/ 110) showed lesions that decrease the diameter of affected vessels by < 25% of the diameter of the adjacent arteries. Only 12% ofthe cine films (13/110) showed lesions of >50% stenosis in the left anterior descending coronary artery. Therefore, the degree of luminal obstruction was usually not severe. The disease, however, often affects different portions ofthe same artery as well as other vessels. This pattern of distribution of the disease makes accurate anatomical description difficult.
GRAFT FAILURE
Coronary occlusive disease caused failure of 26 grafts (20%) compared with 132 graft losses from all causes during this period. Most of these patients died later than one year after operation (table 1). Thirteen patients who had undergone coronary angiography died and the heart was available for full examination. Seven patients underwent eight cardiac retransplantation operations. The remaining five patients died and had necropsies, but the heart was not examined at this hospital.
The mean age of all patients at the time of graft failure was 39 (range 23-57) years. The median time from the identification of coronary occlusive disease angiographically to death in the group dying of coronary occlusive disease was 2-3 (range 0-1-5-6) years. Twelve of the 13 patients who died and had post mortem 30 The lack of suitable treatment for coronary occlusive disease calls into question the clinical value of routine coronary angiography in the follow up of symptom free cardiac transplant patients after operation. This contrasts with its research role, where it is clear that although more patients are required, risk factor analysis may eventually provide insights into associated cofactors in development of disease. The presence of severe lesions in larger coronary arteries is likely to be associated with a poor prognosis as suggested by our study. The mortality data, however, suggests that moderate epicardial coronary disease and disease in smaller vessels are also important in the increased mortality in long-term heart transplant patients. Ventricular hypertrophy may also be an important risk factor.
Non-invasive methods of detection of coronary occlusive disease have been disappointing.3" We should therefore attempt to use newer methods of measuring impairment of myocardial perfusion and function produced by coronary occlusive disease.32 With this information, improved preventive and therapeutic strategies for long-term cardiac transplant patients with coronary occlusive disease could be made.
In conclusion coronary occlusive disease is the main cause of late mortality and morbidity in cardiac transplant patients. Coronary disease affecting primary and secondary coronary arteries is the main factor in late mortality after cardiac transplantation, although disease in smaller distal vessels and ventricular hypertrophy are also implicated. Improved methods of measuring impairment of myocardial perfusion and function produced by coronary occlusive disease should be developed.
